Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Sarcoma, Ewing × romiplostim × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thrombocytopenia 4 Lymphoma, Non-Hodgkin 4 Multiple Myeloma 3 Hodgkin Disease 2 Solid Tumor 1 Sarcoma, Ewing 1 Ovarian Neoplasms 1 Neoplasms 1 Melanoma 1 Lymphoma, Mantle-Cell 1 Lymphoma 1 Leukemia, Monocytic, Acute 1 Leukemia, Lymphoid 1 Hematologic Neoplasms 1 Glioblastoma 1

Interventions

Cyclophosphamide 15 Temozolomide 12 Vincristine 9 Irinotecan 8 Melphalan 7 Doxorubicin 7 Topotecan 6 Granulocyte Colony-Stimulating Factor 6 Busulfan 6 Etoposide 5 Drug Therapy 5 liposomal doxorubicin 4 fludarabine 4 cabozantinib 4 Sirolimus 4 Ifosfamide 4 Filgrastim 4 pegfilgrastim 3 fludarabine phosphate 3 Zoledronic Acid 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Cisplatin 3 Bone Marrow Transplantation 3 regorafenib 2 pegylated granulocyte colony-stimulating factor 2 olaparib 2 irinotecan sucrosofate 2 ganitumab 2 Vinorelbine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07048249 2026-03-18

Single Arm Romiplostim to Prevent CIT

Children's Hospital Medical Center, Cincinnati

Phase EARLY_PHASE1 Recruiting

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡